ArticleGynecologic oncology reports2024

Dehydrated amniotic membrane patch for the treatment of an ocular event secondary to mirvetuximab soravtansine-gynx (MIRV) therapy.

Brittany File et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.